ATPC - Agape ATP Total Debt to Capital

Public company logo of Agape ATP Corp (ATPC)

The price evolution of Agape ATP Corporation (ATPC) helps assess the debt load of a business that relies on the sale of nutraceuticals for cellular energy amid low pricing power and elastic demand, where the metric stands at 0.00. Growth is based on alliances with Asian metabolism control clinics. Stability is ensured by sophisticated raw material logistics and the availability of warehouse inventories, which eliminate supply disruptions.

ATPC: Agape ATP Corp. Total Debt to Capital 02/21/2024 - 10/31/2026
Core merchandise of Agape ATP

For Agape ATP Corporation (ATPC), which monetizes demand for dietary supplements through established distribution, this indicator serves as a measure of financial leverage resilience in the face of market risks. Comparing total liabilities to net assets within the debt-to-equity ratio trend reveals the extent of the business's reliance on borrowed funds, determining the fundamental reliability of capital and the company's ability to maintain operations without a critical debt burden.

Competitor analysis for Agape ATP Corporation

Debt to Equity Ascendis Pharma|Madrigal Pharmaceuticals Inc - Aggregate Debt to Equity|Total Debt to Capital CORT|RYTM (Rhythm Corp) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital AKRO (Akero Therapeutics)|Total Debt to Capital metsera.com MTSR|MLTX - Debt to Equity|All Debt to Shareholders' Equity Ratio CRNX (Crinetics Pharmaceuticals, Inc.)|NewAmsterdam Pharma N.V. (NAMS) - Debt to Equity|Total Debt to Equity Ratio Soleno Therapeutics Corp|FOLD (Amicus Therapeutics) - Total Debt to Capital|Total Debt to Capital 89bio.com|Total Debt to Equity Ratio AGIO (Agios Pharmaceuticals, Inc.)|GPCR (Structure Therapeutics Inc) - All Debt to Shareholders' Equity Ratio|Debt to Equity MiMedx Group MDXG|RZLT - Total Debt to Equity Ratio|Lexicon Pharmaceuticals - Total Debt to Capital|Debt to Capital mbxbio.com|ALT (Altimmune) - Total Debt to Equity Ratio|AARD: Aggregate Debt to Capital|SGMT (Sagimet) - Total Debt to Capital|Total Debt to Capital BioAge Labs, Inc|Total Debt to Capital BMEA|Debt to Equity QNCX (quincetx.com)|Debt to Equity Fractyl Health GUTS|vTv Therapeutics, Inc. (VTVT) - Debt to Capital|PLUR - Debt to Equity|SYBX: Debt to Equity|LPCN: Total Debt to Capital|MTNB - Total Debt to Capital Coefficient|Debt to Equity Spruce Biosciences, Inc.|Galecto Inc (GLTO) - Total Debt to Capital Coefficient|Debt to Equity Carmell Corp (CTCX)|Total Debt to Equity Ratio Lumos Therapeutics LUMO|Total Debt to Capital ONVO (Organovo Holdings, Inc.)|Total Debt to Capital radiuspharm.com RDUS